摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(3-bromophenyl)-N'-cyano-2-(4-fluorobenzyl)-4-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazine-1-carboximidamide | 1116570-85-4

中文名称
——
中文别名
——
英文名称
N-(3-bromophenyl)-N'-cyano-2-(4-fluorobenzyl)-4-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazine-1-carboximidamide
英文别名
N'-(3-bromophenyl)-N-cyano-2-[(4-fluorophenyl)methyl]-4-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazine-1-carboximidamide
N-(3-bromophenyl)-N'-cyano-2-(4-fluorobenzyl)-4-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazine-1-carboximidamide化学式
CAS
1116570-85-4
化学式
C26H24BrFN8
mdl
——
分子量
547.433
InChiKey
CAWMJJPKCSDLSA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.3
  • 重原子数:
    36
  • 可旋转键数:
    6
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    96.2
  • 氢给体数:
    2
  • 氢受体数:
    6

文献信息

  • (7H-PYRROLO [2, 3-D] PYRIMIDIN-4-YL) -PIPERAZINES AS KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATION
    申请人:Lexicon Pharmaceuticals, Inc.
    公开号:EP2597098A1
    公开(公告)日:2013-05-29
    Inhibitors of LIM kinase 2 of the following formula are disclosed, along with pharmaceutical compositions comprising them and methods of their use, in particular for treatment of inflammatory and cancerous and ocular diseases. X is O or NRA; A is cycloalkyl, aryl or heterocyclyl; RA is hydrogen, cyano, nitro, RA1, SO2RA1 or SO2N(RA1)2; each RB is independently hydrogen or alkyl. The other variables are as defined in the claims.
    本研究公开了下式的 LIM 激酶 2 抑制剂,以及包含这些抑制剂的药物组合物和使用方法,尤其是用于治疗炎症、癌症和眼部疾病的方法。 X 是 O 或 NRA; A 是环烷基、芳基或杂环基; RA 是氢、基、硝基、RA1、SO2RA1 或 SO2N(RA1)2 每个 RB 独立地为氢或烷基。 其他变量如权利要求中所定义。
  • (7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-PIPERAZINES AS KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATION
    申请人:Lexicon Pharmaceuticals, Inc.
    公开号:EP2188289B1
    公开(公告)日:2015-10-28
  • [EN] KINASE INHIBITORS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE<br/>[FR] INHIBITEURS DE KINASE, COMPOSITIONS LES CONTENANT ET PROCÉDÉS D'UTILISATION
    申请人:LEXICON PHARMACEUTICALS INC
    公开号:WO2009021169A2
    公开(公告)日:2009-02-12
    Inhibitors of LIM kinase 2 are disclosed, along with pharmaceutical compositions com πsin them and methods of their use. X is O or NRA; Y is O, NRR, or C(RR)2; A is cycloalkyl, aryl or hctcrocyclc; RA is hydrogen, cyano, nitro, RA1, SO2RA1, SO2NRA1, or SO2N(RA1)2;
查看更多